1. Home
  2. FCUV vs GBIO Comparison

FCUV vs GBIO Comparison

Compare FCUV & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FCUV
  • GBIO
  • Stock Information
  • Founded
  • FCUV 2012
  • GBIO 2016
  • Country
  • FCUV United States
  • GBIO United States
  • Employees
  • FCUV N/A
  • GBIO N/A
  • Industry
  • FCUV Industrial Machinery/Components
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • FCUV Industrials
  • GBIO Health Care
  • Exchange
  • FCUV Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • FCUV 27.6M
  • GBIO 29.2M
  • IPO Year
  • FCUV N/A
  • GBIO 2020
  • Fundamental
  • Price
  • FCUV $3.77
  • GBIO $0.39
  • Analyst Decision
  • FCUV
  • GBIO Strong Buy
  • Analyst Count
  • FCUV 0
  • GBIO 4
  • Target Price
  • FCUV N/A
  • GBIO $7.33
  • AVG Volume (30 Days)
  • FCUV 13.7K
  • GBIO 1.1M
  • Earning Date
  • FCUV 08-13-2025
  • GBIO 08-06-2025
  • Dividend Yield
  • FCUV N/A
  • GBIO N/A
  • EPS Growth
  • FCUV N/A
  • GBIO N/A
  • EPS
  • FCUV N/A
  • GBIO N/A
  • Revenue
  • FCUV $408,887.00
  • GBIO $24,556,000.00
  • Revenue This Year
  • FCUV N/A
  • GBIO N/A
  • Revenue Next Year
  • FCUV N/A
  • GBIO N/A
  • P/E Ratio
  • FCUV N/A
  • GBIO N/A
  • Revenue Growth
  • FCUV 6.49
  • GBIO 146.47
  • 52 Week Low
  • FCUV $1.50
  • GBIO $0.30
  • 52 Week High
  • FCUV $10.90
  • GBIO $3.65
  • Technical
  • Relative Strength Index (RSI)
  • FCUV 41.10
  • GBIO 52.02
  • Support Level
  • FCUV $3.75
  • GBIO $0.32
  • Resistance Level
  • FCUV $4.23
  • GBIO $0.36
  • Average True Range (ATR)
  • FCUV 0.23
  • GBIO 0.03
  • MACD
  • FCUV -0.00
  • GBIO 0.00
  • Stochastic Oscillator
  • FCUV 23.61
  • GBIO 81.00

About FCUV Focus Universal Inc.

Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: